Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease

Mov Disord. 2023 Jan;38(1):153-155. doi: 10.1002/mds.29246. Epub 2022 Oct 19.
No abstract available

Keywords: Biomarkers; RT-QuIC; Saliva; alpha-synuclein.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Humans
  • Parkinson Disease*
  • Patient Acuity
  • alpha-Synuclein

Substances

  • alpha-Synuclein
  • Biomarkers